Prep pathways that adapt
Pick the prep your clinic uses. The pathway adapts to the patient in front of it. Diabetic, IBD, constipation, prior-failed-prep, elderly, all covered without rewriting the page.
HospitalsAescia for Hospitals is an investigational Software as a Medical Device under the TGA Class IIa pathway. Not yet available for commercial supply.
ClinicsAescia for Clinics is a workflow and patient-preparation tool. It does not propose clinical decisions and is not a medical device.
Aescia for Clinics is a workflow platform for specialty clinics, with endoscopy as the first home. Pre-procedure pathways delivered by SMS and email into a patient web-app. Diabetic, anticoagulant, and GLP-1 overlays. Recall tracking that stops slipping. It does not propose clinical decisions. It is not a medical device.
Posture
Not a medical device. Not a decision tool.
A workflow and patient-preparation platform. Does not diagnose, does not treat, does not propose clinical decisions.
Pick the prep your clinic uses. The pathway adapts to the patient in front of it. Diabetic, IBD, constipation, prior-failed-prep, elderly, all covered without rewriting the page.
Timed reminders in the patient language, a confirm-and-reschedule path built in, a same-day flag your front desk can actually act on. Waitlist auto-fill on cancellation.
Patient self-reports the medication and the dose. The pathway delivers the clinician-authored instruction that corresponds to the patient's report, aligned with the 2024 multi-society guidance and the 2025 international consensus. Decisions remain with the proceduralist.
SGLT2, metformin, DOAC, and warfarin scenarios delivered as clinician-authored instructions, generated from the patient's answers. The clinician signs off the rule set, not the vendor.
The evening before, the patient can upload a toilet-bowl photo through the web-app. The pathway auto-rates it against a clinician-set rubric and either confirms the slot or triggers rescheduling before the patient leaves home.
Two-way messaging by SMS and email answers the top twenty prep questions before they reach the front desk, using templated clinician-authored responses. The clinic sees the exceptions, not every message.
High-risk polyp follow-up and surveillance intervals do not rely on a spreadsheet anyone might miss. Named patients, named dates, named triggers, aligned with USMSTF and NHMRC interval guidance.
Works alongside common endoscopy reporting (Provation, EndoWorks, gGastro) and practice-management systems. Adds a signal layer without a second login for your team.
Configured by one clinic admin in an afternoon. Flat monthly pricing per specialty. Designed to go live in weeks once a champion is in place, not quarters.
This is not a hospital discharge tool dressed for a clinic. It is a prep and workflow product with its own authored protocols, its own SMS layer, and its own vocabulary: today's list, room utilisation, case turnover, prep adequacy, recall compliance.
The pathway covers regional brand equivalents across the markets we support. Clinicians in each country see the prep names their patients see on the shelf.
Endoscopy is the first clinical focus: colonoscopy and gastroscopy pathway development is active, with regional bowel-prep variants and specialty overlays in build. The same engine extends to physiotherapy post-discharge, aesthetics, and other efficiency-seeking specialties as clinical champions join. If your specialty is not listed, we will build the pathway with you.
We do not prescribe which specialties belong on the platform. We ask whether the friction is real, whether there is a clinician willing to co-author the pathway, and whether the patient journey has the kind of between-visit gap the engine can bridge.
A busy endoscopy list loses more to cancelled prep, GLP-1 confusion, and follow-up drift in a week than Aescia costs for the month. The economic case is subtractive: less phone work at the front desk, fewer repeat appointments on inadequate prep, fewer recall patients lost to the wind.
Mehta 2021
Allen 2023, CMS ASC fees CPT 45378–45385
Beran 2024, n=358,257
Lebwohl 2011
Public and modelled figures. Site-specific ROI requires a scoped evaluation against your own list volume, no-show rate, and prep-inadequacy baseline.
Flat monthly by specialty at the single-site level, consumption-aligned at scale. Starts below the cost of one missed no-show per week. We publish a posture, not a list: clinics pay for a specialty protocol they can deploy inside two weeks, and scale adds protocols, not friction.
Ask about your specialty